Ae. Gulyaev et al., Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles, PHARM RES, 16(10), 1999, pp. 1564-1569
Purpose. To investigate the possibility of delivering of anticancer drugs i
nto the brain using colloidal carriers (nanoparticles).
Methods. Rats obtained 5 mg/kg of doxorubicin by i. v. injection in form of
4 preparations : i. a simple solution in saline, 2. a simple solution in p
olysorbate 80 1% in saline, 3.bound to poly(butyl cyanoacrylate) nanopartic
les, and 4. bound to poly(butyl cyanoacrylate) nanoparticles overcoated wit
h 1% polysorbate 80 (Tween(R) 80). After sacrifice of the animals after 10
min, 1, 2, 4, 6, and 8 hours, the doxorubicin concentrations in plasma, liv
er, spleen, lungs, kidneys, heart and brain were determined after extractio
n by HPLC.
Results. No significant difference in the body distribution was observed be
tween the two solution formulations. The two nanoparticle formulations very
significantly decreased the heart concentrations. High brain concentration
s of doxorubicin (>6 mu g/g) were achieved with the nanoparticles overcoate
d with polysorbate 80 between 2 and 4 hours. The brain concentrations obser
ved with the other three preparations were always below the detection Limit
(< 0.1 mu g/g).
Conclusions. The present study demonstrates that the brain concentration of
systemically administered doxorubicin can be enhanced over 60-fold by bind
ing to biodegradable poly(butyl cyanoacrylate) nanoparticles, overcoated wi
th the nonionic surfactant polysorbate 80. It is highly probable that coate
d particles reached the brain intact and released the drug after endocytosi
s by the brain blood vessel endothelial cells.